Di Nuzzo Private Wealth, Inc. Neogenomics Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $634 Million
- Q3 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 11 shares of NEO stock, worth $186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 6
83.33%
Holding current value
$186
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NEO
# of Institutions
295Shares Held
125MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$333 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$238 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$117 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$112 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$111 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.13B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...